Literature DB >> 34072267

The Involvement of Ubiquitination Machinery in Cell Cycle Regulation and Cancer Progression.

Tingting Zou1, Zhenghong Lin1.   

Abstract

The cell cycle is a collection of events by which cellular components such as genetic materials and cytoplasmic components are accurately divided into two daughter cells. The cell-cycle transition is primarily driven by the activation of cyclin-dependent kinases (CDKs), the activities of which are regulated by the ubiquitin-mediated proteolysis of key regulators such as cyclins and CDK inhibitors (CKIs). Thus, the ubiquitin-proteasome system (UPS) plays a pivotal role in the regulation of the cell-cycle process via recognition, interaction, and ubiquitination or deubiquitination of key proteins. The illegitimate degradation of tumor suppressor proteins and oncoproteins or, inversely, abnormally high accumulation results in cell proliferation deregulation, genomic instability, and cancer occurrence. In this review, we demonstrate the diversity and complexity of the UPS machinery regulation of the cell cycle. A profound understanding of the ubiquitination machinery will provide new insights into the regulation of the cell-cycle transition, cancer treatment, and the development of anti-cancer drugs.

Entities:  

Keywords:  CDKs; CKIs; DUBs; E3 ubiquitin ligases; UPS; cell-cycle regulation; cyclins

Year:  2021        PMID: 34072267     DOI: 10.3390/ijms22115754

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  235 in total

1.  The F-box protein SKP2 binds to the phosphorylated threonine 380 in cyclin E and regulates ubiquitin-dependent degradation of cyclin E.

Authors:  K H Yeh; T Kondo; J Zheng; L M Tsvetkov; J Blair; H Zhang
Journal:  Biochem Biophys Res Commun       Date:  2001-03-09       Impact factor: 3.575

2.  CRL2(LRR-1) targets a CDK inhibitor for cell cycle control in C. elegans and actin-based motility regulation in human cells.

Authors:  Natalia G Starostina; Jennifer M Simpliciano; Michael A McGuirk; Edward T Kipreos
Journal:  Dev Cell       Date:  2010-11-16       Impact factor: 12.270

3.  Involvement of USP24 in the DNA damage response.

Authors:  Ling Zhang; Feng Gong
Journal:  Mol Cell Oncol       Date:  2015-02-03

4.  Regulation of the Mdm2-p53 pathway by the ubiquitin E3 ligase MARCH7.

Authors:  Kailiang Zhao; Yang Yang; Guang Zhang; Chenfeng Wang; Decai Wang; Mian Wu; Yide Mei
Journal:  EMBO Rep       Date:  2018-01-02       Impact factor: 8.807

5.  Ret finger protein 2 enhances ionizing radiation-induced apoptosis via degradation of AKT and MDM2.

Authors:  Hae Mi Joo; Ji Young Kim; Jae Boon Jeong; Ki Moon Seong; Seon Young Nam; Kwang Hee Yang; Cha Soon Kim; Hee Sun Kim; Meeseon Jeong; Sungkwan An; Young Woo Jin
Journal:  Eur J Cell Biol       Date:  2011-02-17       Impact factor: 4.492

Review 6.  Proteasome inhibitors in cancer therapy.

Authors:  Elisabet E Manasanch; Robert Z Orlowski
Journal:  Nat Rev Clin Oncol       Date:  2017-01-24       Impact factor: 66.675

7.  Intrinsic ubiquitination activity of PCAF controls the stability of the oncoprotein Hdm2.

Authors:  Laëtitia K Linares; Rosemary Kiernan; Robinson Triboulet; Christine Chable-Bessia; Daniel Latreille; Olivier Cuvier; Matthieu Lacroix; Laurent Le Cam; Olivier Coux; Monsef Benkirane
Journal:  Nat Cell Biol       Date:  2007-02-11       Impact factor: 28.824

8.  The herpes simplex virus type 1 (HSV-1) regulatory protein ICP0 interacts with and Ubiquitinates p53.

Authors:  Chris Boutell; Roger D Everett
Journal:  J Biol Chem       Date:  2003-07-09       Impact factor: 5.157

9.  The anaphase-promoting complex is required in G1 arrested yeast cells to inhibit B-type cyclin accumulation and to prevent uncontrolled entry into S-phase.

Authors:  S Irniger; K Nasmyth
Journal:  J Cell Sci       Date:  1997-07       Impact factor: 5.285

10.  USP15 stabilizes MDM2 to mediate cancer-cell survival and inhibit antitumor T cell responses.

Authors:  Qiang Zou; Jin Jin; Hongbo Hu; Haiyan S Li; Simona Romano; Yichuan Xiao; Mako Nakaya; Xiaofei Zhou; Xuhong Cheng; Peirong Yang; Guillermina Lozano; Chengming Zhu; Stephanie S Watowich; Stephen E Ullrich; Shao-Cong Sun
Journal:  Nat Immunol       Date:  2014-04-28       Impact factor: 25.606

View more
  10 in total

1.  USP39 facilitates breast cancer cell proliferation through stabilization of FOXM1.

Authors:  Zhenwang Zhang; Wu Liu; Xiajun Bao; Tian Sun; Jiawei Wang; Mengxi Li; Chao Liu
Journal:  Am J Cancer Res       Date:  2022-08-15       Impact factor: 5.942

2.  Study of tRNA-Derived Fragment tRF-20-S998LO9D in Pan-Cancer.

Authors:  Jinqi Ma; Fengxia Liu
Journal:  Dis Markers       Date:  2022-05-05       Impact factor: 3.464

Review 3.  SUMOylation and NEDDylation in Primary and Metastatic Cancers to Bone.

Authors:  Marta Gomarasca; Giovanni Lombardi; Paola Maroni
Journal:  Front Cell Dev Biol       Date:  2022-04-06

Review 4.  p27, The Cell Cycle and Alzheimer´s Disease.

Authors:  Ana García-Osta; Jinya Dong; María Jesús Moreno-Aliaga; Maria Javier Ramirez
Journal:  Int J Mol Sci       Date:  2022-01-21       Impact factor: 5.923

Review 5.  Autophagy Regulation by Crosstalk between miRNAs and Ubiquitination System.

Authors:  Junyan Qu; Zhenghong Lin
Journal:  Int J Mol Sci       Date:  2021-11-03       Impact factor: 5.923

6.  Plasma Exosomes of Patients with Breast and Ovarian Tumors Contain an Inactive 20S Proteasome.

Authors:  Natalia Yunusova; Elena Kolegova; Elena Sereda; Larisa Kolomiets; Alisa Villert; Marina Patysheva; Irina Rekeda; Alina Grigor'eva; Natalia Tarabanovskaya; Irina Kondakova; Svetlana Tamkovich
Journal:  Molecules       Date:  2021-11-18       Impact factor: 4.411

7.  FOXM1 Is a Novel Molecular Target of AFP-Positive Hepatocellular Carcinoma Abrogated by Proteasome Inhibition.

Authors:  Ru Li; Hikari Okada; Taro Yamashita; Kouki Nio; Han Chen; Yingyi Li; Tetsuro Shimakami; Hajime Takatori; Kuniaki Arai; Yoshio Sakai; Tatsuya Yamashita; Eishiro Mizukoshi; Masao Honda; Shuichi Kaneko
Journal:  Int J Mol Sci       Date:  2022-07-27       Impact factor: 6.208

8.  Proteasomal subunit depletions differentially affect germline integrity in C. elegans.

Authors:  Lourds Michelle Fernando; Cristina Quesada-Candela; Makaelah Murray; Caroline Ugoaru; Judith L Yanowitz; Anna K Allen
Journal:  Front Cell Dev Biol       Date:  2022-08-17

Review 9.  Novel Insights into miR-944 in Cancer.

Authors:  Jinze Shen; Qurui Wang; Chenhao Liang; Xinming Su; Yufei Ke; Yunan Mao; Jie Fang; Shiwei Duan
Journal:  Cancers (Basel)       Date:  2022-08-31       Impact factor: 6.575

Review 10.  Role of USP13 in physiology and diseases.

Authors:  Qian Wang; Zhenzhen Sun; Weiwei Xia; Le Sun; Yang Du; Yue Zhang; Zhanjun Jia
Journal:  Front Mol Biosci       Date:  2022-09-14
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.